SAT518 Real World Use of Systemic Therapy for Treatment of Advanced Thyroid Cancer

Disclosure: D. Chen: None. M. Banerjee: None. T. Xu: None. F.P. Worden: None. M.R. Haymart: None. Background. Since 2011, the United States Food and Drug Administration (FDA) has approved eight small-molecule kinase inhibitors (SMKIs) for the treatment of advanced thyroid cancer (i.e., radioiodine-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Debbie, Banerjee, Mousumi, Xu, Tianyi, Worden, Francis P, Haymart, Megan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553568/
http://dx.doi.org/10.1210/jendso/bvad114.1990

Ejemplares similares

Ejemplares similares